QA: Metavia Inc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001638287_2024_Metavia_Inc.pdf

Logs

warning Missing logo subcommand.report {}
info Ambiguous roles for statement input.sec.calculation_linkbase.expand_agg {'statement': 'operations', 'valid_roles': {'00200 - Statement - Condensed Consolidated Statements of Operations and Comprehensive Loss': 12, '00205 - Statement - Condensed Statements of Comprehensive Loss (Calc 2)': 2}}

Graph

Absolute values for 0001638287, Metavia Inc

  xvar xval
0 AssetsCurrent 22,512,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 46,000
3 remainder_Assets 223,000
4 LiabilitiesCurrent 5,960,000
5 LiabilitiesNoncurrent 136,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 6,656,426
9 ResearchAndDevelopmentExpense 8,870,556
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 3,334,117
13 remainder_ComprehensiveNetIncome 546
  yvar yval
0 Assets 22,781,000
1 Liabilities 6,096,000
2 Expenses 15,526,982
3 Revenues 0
4 StockholdersEquity 16,685,000
5 NetIncome -12,192,865
6 ComprehensiveNetIncome -12,192,592
7 BaseVar 23,869,322
8 EconomicCapitalRatiobeforeLimitedLiability 1.67
9 EconomicCapitalRatio 2.80

Edgar->Model Mapping

Feature Distribution

Change over Time